NPH is not a Biotech companyBiotech referrs (usually) to companies focused on developing technology using human cells or gene decoding to cure sickness and disease... NPH is a pharmaceutical company .... Both are sub-sets of the broader healthcare industry ....BTW generic pharma has not been affected as much is this weeks correction as the much much risker biotech segment...The two sub-segments have totally different risk profiles. IMO the generic pharma space , in general, is the lowest risk economic sector ....and why I think pension money (like Teachers) will be moving into the sector..not to mention funds of all types...